TrialInternational journal of cancer2026
Nimotuzumab Combined With Concurrent Curative Radiotherapy and S-1 in 75 Years and Older Patients With Stage II-IVB Esophageal Squamous Cell Carcinoma: A Phase II Study.
Xiaojie Xia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.